These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9633910)

  • 21. Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type Ib.
    Lachaux A; Boillot O; Stamm D; Canterino I; Dumontet C; Regnier F; Floret D; Hermier M
    J Pediatr; 1993 Dec; 123(6):1005-8. PubMed ID: 7693904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective randomized study comparing the efficacy of bioequivalent doses of glycosylated and nonglycosylated rG-CSF for mobilizing peripheral blood progenitor cells.
    de Arriba F; Lozano ML; Ortuño F; Heras I; Moraleda JM; Vicente V
    Br J Haematol; 1997 Feb; 96(2):418-20. PubMed ID: 9029036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma.
    Lisenko K; Baertsch MA; Meiser R; Pavel P; Bruckner T; Kriegsmann M; Schmitt A; Witzens-Harig M; Ho AD; Hillengass J; Wuchter P
    Transfusion; 2017 Oct; 57(10):2359-2365. PubMed ID: 28653421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost.
    Lee SM; Radford JA; Dobson L; Huq T; Ryder WD; Pettengell R; Morgenstern GR; Scarffe JH; Crowther D
    Br J Cancer; 1998 Apr; 77(8):1294-9. PubMed ID: 9579836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial.
    Linch DC; Milligan DW; Winfield DA; Kelsey SM; Johnson SA; Littlewood TJ; Smith GM; Hutchinson RM; Goldstone AH; Fielding AK; Vaughan Hudson G
    Br J Haematol; 1997 Dec; 99(4):933-8. PubMed ID: 9432046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
    Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
    Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.
    Ocheni S; Zabelina T; Bacher U; Ayuk F; Zander A; Kröger N
    Leuk Lymphoma; 2009 Apr; 50(4):612-8. PubMed ID: 19263295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug eruption caused by recombinant human G-CSF.
    Sasaki O; Yokoyama A; Uemura S; Fujino S; Inoue Y; Kohno N; Hiwada K
    Intern Med; 1994 Oct; 33(10):641-3. PubMed ID: 7530069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors.
    Farhan R; Urbanowska E; Zborowska H; Król M; Król M; Torosian T; Piotrowska I; Bogusz K; Skwierawska K; Wiktor-Jędrzejczak W; Snarski E
    Ann Hematol; 2017 Oct; 96(10):1735-1739. PubMed ID: 28801752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High pregnancy rates with administration of granulocyte colony-stimulating factor in ART-patients with repetitive implantation failure and lacking killer-cell immunglobulin-like receptors.
    Würfel W; Santjohanser C; Hirv K; Bühl M; Meri O; Laubert I; von Hertwig I; Fiedler K; Krüsmann J; Krüsmann G
    Hum Reprod; 2010 Aug; 25(8):2151-2; author reply 2152. PubMed ID: 20522442
    [No Abstract]   [Full Text] [Related]  

  • 31. Granulocyte colony-stimulating factor in the combination chemotherapy for adult T-cell leukemia (ATL).
    Uozumi K; Nakahara K; Takatsuka Y; Ohno N; Makino T; Utsunomiya A; Hanada S; Arima T
    Leuk Lymphoma; 1998 Apr; 29(3-4):407-14. PubMed ID: 9684938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle.
    Blaise D; Kuentz M; Fortanier C; Bourhis JH; Milpied N; Sutton L; Jouet JP; Attal M; Bordigoni P; Cahn JY; Boiron JM; Schuller MP; Moatti JP; Michallet M
    J Clin Oncol; 2000 Feb; 18(3):537-46. PubMed ID: 10653869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
    Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of engraftment of lenograstim mobilised allogeneic peripheral blood progenitor cells in aplastic anaemia.
    Grigg A; Goss G; Szer J
    Aust N Z J Med; 1994 Dec; 24(6):736-7. PubMed ID: 7536409
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.
    Olsson-Strömberg U; Höglund M; Björkholm M; Braide I; Carlson K; Gahrton G; Grimfors G; Hast R; Lerner R; Linder O; Ljungman P; Löfvenberg E; Malm C; Nilsson PG; Paul C; Rödjer S; Stenke L; Tidefeldt U; Turesson I; Uden AM; Wahlin A; Vilen L; Winqvist I; Zettervall O; Oberg G; Simonsson B
    Leuk Lymphoma; 2006 Sep; 47(9):1768-73. PubMed ID: 17064986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose lenograstim to enhance engraftment after autologous stem cell transplantation: a prospective randomized evaluation of two different fixed doses.
    Suh C; Kim HJ; Kim SH; Kim S; Lee SJ; Lee YS; Kim EK; Kim SB; Lee JS; Kim MW; Kim K; Yoon SS
    Transfusion; 2004 Apr; 44(4):533-8. PubMed ID: 15043569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hematopoietic growth factors and autologous or allogeneic stem cell transplantation].
    Bay JO; Peffault de Latour R; Tournilhac O; Choufi B; Chassagne J
    Bull Cancer; 2006 May; 93(5):473-82. PubMed ID: 16777625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human granulocyte colony-stimulating factor infusion and/or autologous peripheral blood stem cell transplantation as a rescue for sequential high-dose combination chemotherapy: a preliminary report.
    Chau WK; Lin CK; Chow MP; Wang SY; Liu JM; Ho CH; Chiu CF; Hsu HC; Tan TD; Chan WK
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):312-20. PubMed ID: 7530591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.
    Danylesko I; Sareli R; Bloom-Varda N; Yerushalmi R; Shem-Tov N; Shimoni A; Nagler A
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):277-283. PubMed ID: 26343949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dose-finding study of glycosylated G-CSF (Lenograstim) combined with CHOP therapy for stem cell mobilization in patients with non-Hodgkin's lymphoma.
    Takeyama K; Ogura M; Morishima Y; Kasai M; Kiyama Y; Ohnishi K; Mitsuya H; Kawano F; Masaki Y; Sasaki T; Chou T; Yokozawa T; Tobinai K;
    Jpn J Clin Oncol; 2003 Feb; 33(2):78-85. PubMed ID: 12629058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.